The Japanese Biochemical Society/The Molecular Biology Society of Japan

11:05 AM - 11:30 AM

[2W6-7] Double-blind placebo-controlled trial of hydrogen water in Parkinson disease.

〇Asako Yoritaka1,2, Masashi Takanashi2, Masaaki Hirayama3, Toshiki Nakahara2, Shigeo Ohta4, Nobutaka Hattori2 (1.Dept,of Neurol.,Juntendo Univ. Koshigaya Hosp., 2.Dept,of Neurol.,Juntendo Univ. Sch. of Med., 3.Dep. of Pathophysiological Lab. Sci., Nagoya Univ.Grad. Sch. of Med., 4.Dep. of Biochem. Cell Biol., Inst. of Development Aging Sci., Nippon Med. Sch.)

Parkinson's disease, hydrogen water

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password